Jones Trading Downgrades Theravance Biopharma to Hold

Benzinga Newsdesk www.benzinga.com Negative 91.3%

Neg 91.3% Neu 0% Pos 0%

Jones Trading analyst Debanjana Chatterjee downgrades Theravance Biopharma (NASDAQ:TBPH) from Buy to Hold.

Comments

No comments yet. Be the first!